BioPlus Acquisition Corp Price Prediction

BIOSWDelisted Stock  USD 0.14  0.00  0.00%   
The value of RSI of BioPlus Acquisition's stock price is slightly above 60 suggesting that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling BioPlus, making its price go up or down.

Oversold Vs Overbought

60

 
Oversold
 
Overbought
The successful prediction of BioPlus Acquisition's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of BioPlus Acquisition and does not consider all of the tangible or intangible factors available from BioPlus Acquisition's fundamental data. We analyze noise-free headlines and recent hype associated with BioPlus Acquisition Corp, which may create opportunities for some arbitrage if properly timed.
Using BioPlus Acquisition hype-based prediction, you can estimate the value of BioPlus Acquisition Corp from the perspective of BioPlus Acquisition response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in BioPlus Acquisition to buy its stock at a price that has no basis in reality. In that case, they are not buying BioPlus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

BioPlus Acquisition after-hype prediction price

    
  USD 0.14  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BioPlus Acquisition's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.110.110.15
Details
Naive
Forecast
LowNextHigh
0.140.140.14
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.130.140.15
Details

BioPlus Acquisition After-Hype Price Prediction Density Analysis

As far as predicting the price of BioPlus Acquisition at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in BioPlus Acquisition or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of BioPlus Acquisition, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

BioPlus Acquisition Estimiated After-Hype Price Volatility

In the context of predicting BioPlus Acquisition's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on BioPlus Acquisition's historical news coverage. BioPlus Acquisition's after-hype downside and upside margins for the prediction period are 0.14 and 0.14, respectively. We have considered BioPlus Acquisition's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.14
0.14
After-hype Price
0.14
Upside
BioPlus Acquisition is very steady at this time. Analysis and calculation of next after-hype price of BioPlus Acquisition Corp is based on 3 months time horizon.

BioPlus Acquisition Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as BioPlus Acquisition is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BioPlus Acquisition backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with BioPlus Acquisition, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
2 Events / Month
1 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.14
0.14
0.00 
0.00  
Notes

BioPlus Acquisition Hype Timeline

BioPlus Acquisition Corp is currently traded for 0.14. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. BioPlus is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on BioPlus Acquisition is about 0.0%, with the expected price after the next announcement by competition of 0.14. The company had not issued any dividends in recent years. Assuming the 90 days horizon the next projected press release will be in a few days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

BioPlus Acquisition Related Hype Analysis

Having access to credible news sources related to BioPlus Acquisition's direct competition is more important than ever and may enhance your ability to predict BioPlus Acquisition's future price movements. Getting to know how BioPlus Acquisition's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how BioPlus Acquisition may potentially react to the hype associated with one of its peers.

BioPlus Acquisition Additional Predictive Modules

Most predictive techniques to examine BioPlus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BioPlus using various technical indicators. When you analyze BioPlus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About BioPlus Acquisition Predictive Indicators

The successful prediction of BioPlus Acquisition stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as BioPlus Acquisition Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of BioPlus Acquisition based on analysis of BioPlus Acquisition hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to BioPlus Acquisition's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to BioPlus Acquisition's related companies.

Story Coverage note for BioPlus Acquisition

The number of cover stories for BioPlus Acquisition depends on current market conditions and BioPlus Acquisition's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BioPlus Acquisition is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BioPlus Acquisition's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

BioPlus Acquisition Short Properties

BioPlus Acquisition's future price predictability will typically decrease when BioPlus Acquisition's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of BioPlus Acquisition Corp often depends not only on the future outlook of the potential BioPlus Acquisition's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioPlus Acquisition's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding597.8 M
Cash And Short Term Investments140.3 K
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Consideration for investing in BioPlus Stock

If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device